Growing a pharma business requires a strategic approach considering the specific context of your company and the pharmaceutical industry as a whole. Here are some general pointers to get you started: Market and Customer: Identify your target customer: Deeply understand the specific needs and challenges of your target audience, whether it's doctors, patients, hospitals, or other healthcare providers. This helps tailor your products, services, and marketing efforts. Focus on unmet needs: Look for gaps in the market where existing solutions are inadequate or unavailable. Addressing unmet needs can give you a competitive edge and drive innovation. Track market trends: Stay updated on regulatory changes, technological advancements, and emerging diseases to adapt your approach and anticipate future opportunities. Products and Services: Invest in R&D: Develop innovative products or differentiate existing ones through unique formulations, delivery methods, or combinations. Remember
Schedules: Schedule A, Schedule B, Schedule C, Schedule D, Schedule E1, Schedule F, Schedule G, Schedule H, Schedule H1, Schedule I, Schedule J, Schedule K, Schedule L1, Schedule M, Schedule M1, Schedule M2, Schedule M3, Schedule N, Schedule O, Schedule P, Schedule Q, Schedule R, Schedule S, Schedule T, Schedule U, Schedule V, Schedule W, Schedule X, Schedule Y
Schedule G describes the list of drugs:
Schedule G (Rule 97):
Schedule G describes the list of drugs:
- Aminopterin
- L-Asparaginase
- Bleomycin
- Busulphan; its salts
- Carbutamide Chlorambucil;its salts
- Chlorothiazide and other derivatives of 1, 2, 4 benzothiadiazine
- Chlorpropamide; its salts
- Chlorthalidone and other derivatives of Chlorobenzene compound
- Cis-Platin
- Cyclophosphamide; its salts
- Cytarabine
- Daunorubicin
- Di-Isopropyl Eluorophosphate
- Disodium Stilboestrol Diphosphate
- Doxorubicin Hydrochloride
- Ethacrynic Acid, its salts
- Ethosuximide
- Glibenclamide Hydantoin; its salts; its derivatives, their salts
- Hydroxyurea
- Insulin, all types
- Lomustine Hydrochloride
- Mannomustine; its salts
- Mercaptopurine; its salts
- Metformin; its salts
- Methsuximide
- Mustine, its salts
- Paramethadione
- Phenacemide
- Phenformin; its salts
- 5-Phenylhydantoin; its alkyl and aryl derivatives; its salts
- Primadone
- Procarpazine Hydrochloride
- Quinthazone
- Sarcolysine
- Sodium-2-Mercaptoethanesulfonate
- Tmoxiten Citrate
- Testolactone
- Thiotepa Tolbutamide
- Tretamine; its salts
- Troxidone
- Antihistaminic substances the following, their salts, their derivatives, salts of their derivatives
- Antazoline
- Bromodiphenhydramine
- Buclizine
- Chlorcyclizine
- Chlorpheniramine Clemizole
- Cyproheptadine
- Diphenhydramine
- Diphenylpyraline Doxylamine
- Succinate Isothipendyl
- Mebhydrolin Napadisylate
- Meclozine
- Phenindamine
- Pheniramine
- Promethazine
- Thenalidine
- Triprolidine
- Substances being tetra-N-Subs. derivatives of Ethylene Diamine or Prophylenediamine.
Note: Preparations containing the above substances excluding those intended for topical or external use are also covered by this Schedule
Labeling requirements:
If product contains a drug substance specified in Schedule G, be labeled with following words in legible black colored font size in completely red rectangular box:
SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision
For more detail refer Drug and Cosmetic Act
Labeling requirements:
If product contains a drug substance specified in Schedule G, be labeled with following words in legible black colored font size in completely red rectangular box:
SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision
For more detail refer Drug and Cosmetic Act
Comments
Post a Comment